Audagnotto S - Search Results

1

Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy.

Scabini S, Trunfio M, Pirriatore V, Imperiale D, Audagnotto S, Bertucci R, Ghisetti V, Cinnirella G, Cistaro A, Perna M, Calcagno A, Di Perri G. Scabini S, et al. Among authors: audagnotto s. Infez Med. 2018 Jun 1;26(2):160-163. Infez Med. 2018. PMID: 29932090 Free article.

2

Successful simplification of HAART in patients with acute primary HIV infection.

Sinicco A, Bonora S, Arnaudo I, Zeme DA, Audagnotto S, Raiteri R, Di Perri G. Sinicco A, et al. Among authors: audagnotto s. J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):69-72. J Biol Regul Homeost Agents. 2002. PMID: 12003178

3

Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitis.

Bonora S, Zanusso G, Raiteri R, Monaco S, Rossati A, Ferrari S, Boffito M, Audagnotto S, Sinicco A, Rizzuto N, Concia E, Di Perri G. Bonora S, et al. Among authors: audagnotto s. Clin Infect Dis. 2003 Jun 1;36(11):1492-5. doi: 10.1086/375066. Epub 2003 May 16. Clin Infect Dis. 2003. PMID: 12766846

4

Clinical pharmacology of antiretroviral therapy.

Di Perri G, Sinicco A, Audagnotto S, Gobbi F, Canta F, Marrone R, Bonora S. Di Perri G, et al. Among authors: audagnotto s. New Microbiol. 2004 Apr;27(2 Suppl 1):131-4. New Microbiol. 2004. PMID: 15646076

5

Blackwater fever in children, Burundi.

Gobbi F, Audagnotto S, Trentini L, Nkurunziza I, Corachan M, Di Perri G. Gobbi F, et al. Among authors: audagnotto s. Emerg Infect Dis. 2005 Jul;11(7):1118-20. doi: 10.3201/eid1107.041237. Emerg Infect Dis. 2005. PMID: 16022794 Free PMC article.

6

Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.

Di Perri G, Aguilar Marucco D, Mondo A, Gonzalez de Requena D, Audagnotto S, Gobbi F, Bonora S. Di Perri G, et al. Among authors: audagnotto s. Expert Opin Drug Saf. 2005 Sep;4(5):821-36. doi: 10.1517/14740338.4.5.821. Expert Opin Drug Saf. 2005. PMID: 16111446 Review.

7

[Ertapenem. A new carbapenem in a single dose for community acquired infection].

Di Perri G, Bargiacchi O, Garazzino S, Audagnotto S, De Rosa FG. Di Perri G, et al. Among authors: audagnotto s. Ann Ital Med Int. 2005 Jul-Sep;20(3):3 p following 204. Ann Ital Med Int. 2005. PMID: 16250188 Review. Italian. No abstract available.

8

Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C.

De Rosa FG, Bargiacchi O, Audagnotto S, Garazzino S, Cariti G, Raiteri R, Di Perri G. De Rosa FG, et al. Among authors: audagnotto s. J Antimicrob Chemother. 2006 Feb;57(2):360-3. doi: 10.1093/jac/dki458. Epub 2006 Jan 5. J Antimicrob Chemother. 2006. PMID: 16396921

9

Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient.

De Rosa FG, Audagnotto S, Bargiacchi O, Garazzino S, Aguilar Marucco D, Veronese L, Canta F, Bonora S, Sinicco A, Di Perri G. De Rosa FG, et al. Among authors: audagnotto s. J Infect. 2006 Nov;53(5):e215-8. doi: 10.1016/j.jinf.2006.01.023. Epub 2006 Mar 20. J Infect. 2006. PMID: 16549201

10

A short course of pegylated interferon-alpha in acute HCV hepatitis.

Calleri G, Cariti G, Gaiottino F, De Rosa FG, Bargiacchi O, Audagnotto S, Quaglia S, De Blasi T, Romano P, Traverso A, Leo G, Carbone R, Del Mastro B, Tinelli M, Caramello P, Di Perri G. Calleri G, et al. Among authors: audagnotto s. J Viral Hepat. 2007 Feb;14(2):116-21. doi: 10.1111/j.1365-2893.2006.00802.x. J Viral Hepat. 2007. PMID: 17244251 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters